Insys Therapeutics (INSY) Tops Q1 EPS by 4c

Insys Therapeutics (NASDAQ: INSY) reported Q1 EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $62 million versus the consensus estimate of $61.31 million.

For earnings history and earnings-related data on Insys Therapeutics (INSY) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22